07/15/2026
Curcumin, the active ingredient of turmeric, from the Curcuma longa plant, has received significant recognition over the past few decades as a potential anticancer agent.
Laboratory research suggests that curcumin may prevent cancer, slow cancer growth, enhance chemotherapyâs effectiveness, and protect healthy cells from radiation therapy damage.
Cancer metabolism is the process by which cancer feeds itself with nutrients and makes energy for its survival.
The exploration of how to starve cancer with drugs and natural supplements is a key cancer-fighting strategy.
In this sense, we aim to prevent sugar, fats, and proteins from nourishing cancer cells.
This strategy weakens cancer cells, making them more vulnerable to cancer treatments.
Curcumin appears to lower blood sugar by improving insulin sensitivity.
Researchers have observed that curcumin can inhibit structures on the cell surface known as glucose transporters.
By the direct inhibition of glucose transporters, curcumin potentially slows glucose uptake and compromises the cancer cellâs growth.
Cancer cells are continually adapting, and they need sources of energy to survive.
If cancer cells are starved of glucose, they can adjust and redirect to other energy sources like glutamine and fat.
Curcumin exhibits its unique anticancer activity by inducing apoptosis and inhibiting proliferation by suppressing various cellular signaling pathways.
Researchers have learned that curcumin may enact these anticancer activities by changing how cancer cells transport and process glutamine.
Curcumin has been shown to inhibit mTOR signaling.
By inhibiting mTOR signaling, the tumor cell cannot produce essential proteins that are crucial regulators for its metabolism.
Ultimately, curcumin makes cancer cells less viable by blocking vital cellular proteins.
Not only does curcumin have the ability to rewire cancer cell metabolism and modulate different cell signaling pathways without harming normal cells, but curcumin also serves as an effective chemosensitizer for other therapeutic drugs.
This includes 5-fluorouracil, doxorubicin, paclitaxel, cisplatin, and celecoxib.
Chemosensitizers are substances that enhance the therapeutic response to chemotherapy and potentially reduce resistance.
Laboratory researchers observed that more colorectal cancer cells died off when curcumin was added to platinum-based chemotherapy drugs.
Curcumin produced synergistic effects with cisplatin and carboplatin and additive effects with oxaliplatin.
Another study investigated the anticancer effects of curcumin combined with chemotherapy on human gastric cancer cells.
Following treatment with curcumin and chemotherapy, cancer cell viability was significantly reduced compared with the untreated control group.
A laboratory study evaluated the impact of curcumin on radiation therapyâs effects on human pancreatic cancer cells.
The researchers observed that curcumin-treated cancer cells had significantly improved response to radiation treatment.
These studies and many more support the potential for concurrent curcumin as a useful strategy for improving chemotherapy and radiation therapy outcomes.
When you are fighting late-stage and challenging cancer, it is essential to support your body in every way possible.
Curcumin is one of many potential anticancer substances to help you fight cancer from every angle, in addition to your oncologist treatments.
for more information on alternative cancer and tumor treatment protocols kindly send me a message on my inbox đĽ
